DAAs Less Likely for Hep C Patients With Alcohol Use Disorder
Those with current alcohol use disorder or abstinent with alcohol use disorder history had lower likelihood of receiving direct-acting antivirals
Those with current alcohol use disorder or abstinent with alcohol use disorder history had lower likelihood of receiving direct-acting antivirals
The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.
The all-oral and combination treatment arms demonstrated statistically significant composite responses of 10.1% and 19.2%, respectively.
Dosage regimens for bepirovirsen explored in phase 2b, randomized, investigator-unblinded trial
The approval was supported by data from a phase 2 trial that included 70 patients aged 12 to less than 18 years with chronic HBV infection.
The MVA-BN vaccine, developed by Bavarian Nordic, was evaluated in a clinical trial.
Any increase in ALT following treatment completion was found to be associated with treatment failure.
Individuals with Medicare and Medicaid have lower odds of treatment initiation than those with private insurance
Unclear whether human adenovirus is the causative agent for acute hepatitis in these children